Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 An
Go back to Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 An| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 3.78 +0.33 (9.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.45 | 52 Week High | $2.43 | |||
| Open | $3.50 | 52 Week Low | $1.05 | |||
| Day High | $3.82 | P/E | N/A | |||
| Day Low | $3.44 | EPS | $-1.79 | |||
| Volume | 8,027,831 | |||||
